LifeBridge Health Study Presented at ASBrS 2026 Reports Intraoperative 3D Imaging Leads to Reduced Margin Positivity Compared with 2D Imaging in Breast-Conserving Surgery

Research presented by LifeBridge Health at the 2026 American Society of Breast Surgeons (ASBrS) Annual Meeting reported lower margin positivity and fewer re-operations when intraoperative 3D specimen imaging was used during breast-conserving surgery.

A team from LifeBridge Health - Dona Hobart, MD, FACS, Sagar D. Patel, DO and Connor Borresen, DO; - presented a retrospective study comparing conventional 2D specimen imaging with 3D volumetric specimen imaging using the Clarix Imaging VSI-360 in patients undergoing breast-conserving surgery for invasive ductal carcinoma and ductal carcinoma in situ.

According to the poster, patients evaluated with intraoperative 3D specimen imaging experienced lower rates of positive or close margins and fewer re-operations compared with those assessed using 2D imaging. Reported re-operation rates decreased from 16.4% to 7.6% in the invasive ductal carcinoma cohort and from 37.1% to 4.9% in the DCIS cohort.

For breast surgery programs, greater emphasis should be placed on integrating intraoperative 3D specimen imaging to improve patients' outcomes yet, validation in multi-institutional prospective cohorts will be essential to confirm these findings.

Source: Patel SD, Borresen C, Hobart D. Advancing Margin Assessment: Intraoperative 3D Imaging Leads to Reduced Margin Positivity Compared with 2D Imaging in Breast-Conserving Surgery. Poster/Abstract #1355, American Society of Breast Surgeons Annual Meeting, 2026.

Read the full poster | See how VSI-360 fits into the OR workflow → https://www.breastsurgeons.org/meeting/2026/docs/2026_Official_Proceedings_ASBrS.pdf

Results are based on customer-led research presented at ASBrS 2026. Findings should be interpreted within the context of the study design and patient population.